Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail ...Middle East

Business Standard - Economy
Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail
The antibody treatment is based on ADG20, a novel monoclonal antibody, which targets the spike protein of SARS-CoV-2 and related coronaviruses

Hence then, the article about coronavirus live biocon joins adagio for licence to make antibody cocktail was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 11 hour & 51 minute
before 12 hour & 45 minute